NCT01541397
Phenylketonuria, Hyperphenylalaninemia
The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.
Prospective study to compare the bone mineral density in adults with HPA on KUVAN™ therapy to those not on therapy. The investigators hypothesize that after one year of KUVAN™ therapy, there will be an improvement in their bone mineral density.
All
18 Years to 50 Years
Yes
Sapropterin
Na
Interventional
6
2011-06
2015-07-07
Houston, Texas, United States
*required fields
"*" indicates required fields